CANIFERON Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for CANIFERON with the United States Patent and Trademark Office. The USPTO has given the CANIFERON trademark a serial number of 79327653. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by ILC Therapeutics Limited. The CANIFERON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and ...
caniferon

General Information


Serial Number79327653
Word MarkCANIFERON
Filing DateThursday, September 16, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966132
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameILC Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameILC Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameILC Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 5, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 5, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2022ASSIGNED TO EXAMINER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 19, 2022REFUSAL PROCESSED BY IB
Friday, June 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 24, 2022REFUSAL PROCESSED BY MPU
Wednesday, June 22, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 21, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Tuesday, December 14, 2021APPLICATION FILING RECEIPT MAILED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB